13F-HR filed by JW Asset Management, LLC
JW Asset Management, LLC filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-12, with 22 holding rows worth $93,987,000.
- Accession
- 0001420506-18-000123
- Filer
- CIK 1549738
- Filed
- 2018-02-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2017
A holdings report, 22 entries on the cover page, a total value of $93,987,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $93,987,000 with VALUE read as thousands by filing date, 13F file number 028-16404. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 475,755 | $25,415,000 | thousands by filing date | |
| Amazon.com, Inc | 023135106 | COM | 19,627 | $22,953,000 | thousands by filing date | |
| META PLATFORMS INC CL A | 30303M102 | COM | 37,500 | $6,617,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 270,775 | $3,953,000 | thousands by filing date | |
| ANTARES PHARMA INC | 036642106 | COM | 1,878,323 | $3,738,000 | thousands by filing date | |
| PETIQ INC | 71639T106 | COMMON STOCK | 168,855 | $3,688,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 444,439 | $3,644,000 | thousands by filing date | |
| Microsoft Corp | 594918104 | COM | 41,500 | $3,550,000 | thousands by filing date | |
| BIOSPECIFICS TECHNOLOGIES | 090931106 | COM | 73,649 | $3,191,000 | thousands by filing date | |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 17,750 | $3,061,000 | thousands by filing date | |
| CAMBREX CORP | 132011107 | COM | 50,519 | $2,425,000 | thousands by filing date | |
| JUNIPER PHARMACEUTICALS INC COM | 48203L107 | Stock | 426,903 | $2,070,000 | thousands by filing date | |
| CUMBERLAND PHARMACEUTICALS I | 230770109 | COM | 263,881 | $1,942,000 | thousands by filing date | |
| LIGAND PHARMACEUTICALS INC | 53220K504 | COM NEW | 13,401 | $1,835,000 | thousands by filing date | |
| Micron Technology,Inc. | 595112103 | COM | 41,000 | $1,686,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 966,000 | $1,285,000 | thousands by filing date | |
| NOVELION THERAPEUTICS INC | 67001K202 | COM NEW | 315,979 | $986,000 | thousands by filing date | |
| BED BATH & BEYOND INC | 690370101 | COM | 10,000 | $639,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 178,654 | $625,000 | thousands by filing date | |
| ARALEZ PHARMACEUTICALS INC | 03852X100 | COM | 289,664 | $411,000 | thousands by filing date | |
| SONOMA PHARMACEUTICALS INC | 83558L105 | COM | 40,951 | $223,000 | thousands by filing date | |
| TELIGENT INC NEW | 87960W104 | COM | 13,820 | $50,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-18-000123 | this filing | 2018-02-12 | acceptance time not in the bulk data set |